Last updated: 13 August 2019 at 7:43am EST

Alfred G Gilman Net Worth




The estimated Net Worth of Alfred G Gilman is at least $15.1 Million dollars as of 6 August 2015. Alfred Gilman owns over 5,000 units of Lilly(Eli) & Co stock worth over $12,811,422 and over the last 21 years Alfred sold LLY stock worth over $2,304,800.

Alfred Gilman LLY stock SEC Form 4 insiders trading

Alfred has made over 20 trades of the Lilly(Eli) & Co stock since 2003, according to the Form 4 filled with the SEC. Most recently Alfred exercised 5,000 units of LLY stock worth $285,550 on 6 August 2015.

The largest trade Alfred's ever made was selling 60,000 units of Lilly(Eli) & Co stock on 11 September 2003 worth over $1,289,400. On average, Alfred trades about 7,614 units every 99 days since 2003. As of 6 August 2015 Alfred still owns at least 13,912 units of Lilly(Eli) & Co stock.

You can see the complete history of Alfred Gilman stock trades at the bottom of the page.



What's Alfred Gilman's mailing address?

Alfred's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.

Insiders trading at Lilly(Eli) & Co

Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover, and Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.



What does Lilly(Eli) & Co do?

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.



Complete history of Alfred Gilman stock trades at Regeneron Pharmaceuticals and Lilly(Eli) & Co

Insider
Trans.
Transaction
Total value
Alfred G Gilman
Director
Option $285,550
6 Aug 2015
Alfred G Gilman
Director
Option $1,438,400
24 Nov 2014
Alfred G Gilman
Director
Option $93,050
21 Feb 2014
Alfred G Gilman
Director
Option $93,050
11 Feb 2014
Alfred G Gilman
Director
Option $93,050
14 Jan 2014
Alfred G Gilman
Director
Option $653,100
6 May 2013
Alfred G Gilman
Director
Option $237,000
7 Aug 2012
Alfred G Gilman
Director
Option $362,700
14 Feb 2012
Alfred G Gilman
Director
Sale $1,015,400
29 Apr 2011
Alfred G Gilman
Director
Option $714,300
17 Mar 2011
Alfred G Gilman
Director
Option $127,150
27 May 2010
Alfred G Gilman
Director
Option $76,600
21 Jan 2009
Alfred G Gilman
Director
Option $79,100
20 Feb 2008
Alfred G Gilman
Director
Option $13,832
26 Feb 2007
Alfred G Gilman
Director
Option $84,968
26 Feb 2007
Alfred G Gilman
Director
Option $10,800
6 Jan 2006
Alfred G Gilman
Director
Option $109,200
6 Jan 2006
Alfred G Gilman
Director
Option $128,124
28 Feb 2005
Alfred G Gilman
Director
Option $143,058
7 Feb 2005
Alfred G Gilman
Director
Sale $1,289,400
11 Sep 2003


Lilly(Eli) & Co executives and stock owners

Lilly(Eli) & Co executives and other stock owners filed with the SEC include: